Squarepoint’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6,776
Closed -$541K 3996
2021
Q1
$541K Buy
6,776
+1,313
+24% +$103K ﹤0.01% 1959
2020
Q4
$431K Buy
5,463
+463
+9% +$27.2K ﹤0.01% 1917
2020
Q3
$220K Sell
5,000
-10,532
-68% -$519K ﹤0.01% 2027
2020
Q2
$687K Sell
15,532
-6,612
-30% -$247K 0.01% 1137
2020
Q1
$795K Buy
+22,144
New +$1.26M 0.02% 819
2019
Q4
Sell
-19,150
Closed -$1.43M 2944
2019
Q3
$1.43M Buy
19,150
+8,809
+85% +$747K 0.01% 1001
2019
Q2
$834K Buy
10,341
+155
+2% +$10.9K 0.01% 1370
2019
Q1
$681K Sell
10,186
-21,294
-68% -$1.61M 0.01% 1321
2018
Q4
$2.34M Sell
31,480
-2,022
-6% -$167K 0.03% 621
2018
Q3
$3.08M Sell
33,502
-51,767
-61% -$4.93M 0.04% 572
2018
Q2
$8.39M Buy
85,269
+80,127
+1,558% +$8.96M 0.11% 279
2018
Q1
$573K Buy
5,142
+1,844
+56% +$207K 0.01% 1039
2017
Q4
$339K Sell
3,298
-8,901
-73% -$887K 0.01% 1422
2017
Q3
$1.15M Buy
+12,199
New +$963K 0.02% 679
2016
Q3
Sell
-4,654
Closed -$320K 1358
2016
Q2
$320K Buy
+4,654
New +$321K 0.02% 709

Squarepoint's CMD Position: Q2 2021 in Review

Squarepoint sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 6,776 shares — an estimated $541K sold.

Squarepoint first reported a position in CMD in Q2 2016 and held it in 15 quarters. The position peaked at $8.39M in Q2 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Squarepoint reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Squarepoint sold 6,776 Cantel Medical Corporation shares in Q2 2021, an estimated $541K.
  • Squarepoint first reported a position in Cantel Medical Corporation in Q2 2016 and held it in 15 quarters.
  • Squarepoint's Cantel Medical Corporation position peaked at $8.39M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.